Recent Posts
- Gubra and Bayer AG collaborate to develop next generation cardiorenal treatments
- Drug candidate from obesity collaboration between Gubra and Boehringer Ingelheim enters clinical phase 1 trial
- Annual results 2020: A thriving core business and razor-sharp biotech profile
- Gubra wins sustainability prize 2020
- Boehringer Ingelheim and Gubra Join Forces to Identify and Validate Innovative Peptides for the Treatment of Obesity
Recent Comments